California State Teachers Retirement System Has $13.59 Million Stock Holdings in Align Technology, Inc. $ALGN

Key Points

• California State Teachers Retirement System increased its Align Technology stake by 21.2% in the first quarter, bringing its holdings to 79,293 shares valued at approximately $13.59 million. Institutional investors collectively own 88.43% of the company.
• Align Technology’s second-quarter results exceeded expectations, with adjusted EPS of $2.64 and revenue of about $1.06 billion, up 4.3% year over year. Record Clear Aligner shipments and improved margins supported results, although softer systems performance and modest growth remain concerns.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and average price target of $206.36 versus an opening price of $169.16. The company also authorized a $200 million share-repurchase program, covering up to 1.6% of outstanding shares.

California State Teachers Retirement System grew its position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 21.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,293 shares of the medical equipment provider's stock after buying an additional 13,867 shares during the period. California State Teachers Retirement System owned approximately 0.11% of Align Technology worth $13,593,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of ALGN. Capital International Investors grew its stake in shares of Align Technology by 52.2% in the fourth quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider's stock valued at $725,039,000 after acquiring an additional 1,592,848 shares in the last quarter. Ruane Cunniff & Goldfarb L.P. bought a new position in Align Technology during the fourth quarter worth about $190,899,000. Norges Bank acquired a new stake in Align Technology in the 4th quarter worth about $155,556,000. Assenagon Asset Management S.A. raised its stake in Align Technology by 413.0% in the 1st quarter. Assenagon Asset Management S.A. now owns 989,388 shares of the medical equipment provider's stock worth $169,611,000 after purchasing an additional 796,529 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Align Technology by 247.3% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,005,413 shares of the medical equipment provider's stock valued at $156,995,000 after purchasing an additional 715,919 shares during the period. Institutional investors and hedge funds own 88.43% of the company's stock.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Align Technology Price Performance

ALGN stock opened at $169.16 on Monday. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $200.43. The firm has a market cap of $12.12 billion, a P/E ratio of 29.42, a P/E/G ratio of 1.78 and a beta of 1.65. The company's 50-day moving average price is $174.55 and its two-hundred day moving average price is $175.23.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating the consensus estimate of $2.62 by $0.02. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The company had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.05 billion. During the same period in the previous year, the company earned $2.49 EPS. The business's revenue for the quarter was up 4.3% compared to the same quarter last year. Equities analysts predict that Align Technology, Inc. will post 9.48 EPS for the current year.

Align Technology announced that its board has authorized a stock repurchase program on Wednesday, April 29th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to repurchase up to 1.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board of directors believes its shares are undervalued.

Analysts Set New Price Targets

ALGN has been the topic of a number of analyst reports. UBS Group restated a "neutral" rating and set a $189.00 target price on shares of Align Technology in a research report on Thursday, July 23rd. BMO Capital Markets initiated coverage on shares of Align Technology in a research report on Wednesday, July 8th. They issued an "outperform" rating and a $209.00 price target for the company. Evercore boosted their price target on Align Technology from $200.00 to $220.00 in a research note on Thursday, April 30th. Morgan Stanley increased their price target on Align Technology from $169.00 to $188.00 and gave the stock an "equal weight" rating in a research report on Friday, April 24th. Finally, Wall Street Zen lowered Align Technology from a "strong-buy" rating to a "buy" rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $206.36.

About Align Technology

Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source